Stay updated on CP-690,550 Doses vs. Placebo in Arthritis Clinical Trial

Sign up to get notified when there's something new on the CP-690,550 Doses vs. Placebo in Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CP-690,550 Doses vs. Placebo in Arthritis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:49:21.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the study details related to the Phase 3 study on CP-690,550 for the treatment of rheumatoid arthritis in patients on other background arthritis medications.
    Difference
    0.1%
    Check dated 2024-06-06T14:43:35.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants, specifying that patients must have a diagnosis of Rheumatoid Arthritis and meet certain health conditions. Previously, no information was provided under Participation Criteria Collaborators.
    Difference
    13%
    Check dated 2024-05-22T20:55:12.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:36:58.000Z thumbnail image

Stay in the know with updates to CP-690,550 Doses vs. Placebo in Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CP-690,550 Doses vs. Placebo in Arthritis Clinical Trial page.